Austin W. Marxe & David M. Greenhouse’s Regulus Therapeutics RGLS Stock Holding History

Austin W. Marxe & David M. Greenhouse’s Portfolio RGLS Stock Details RGLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$1.54M	Hold	1,875	–	–	0.21%	100
2014 Q2	$1.81M	Hold	1,875	–	–	0.23%	99
2014 Q1	$2.03M	Sell	1,875 -9,651	-84%	-$10.7M	0.22%	92
2013 Q4	$10.2M	Sell	11,526 -309	-3%	-$266K	1.1%	28
2013 Q3	$13.4M	Hold	11,835	–	–	1.64%	17
2013 Q2	$13.9M	Buy	+11,835	New	+$11.3M	1.88%	12

Other funds holding RGLS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Austin W. Marxe & David M. Greenhouse's RGLS Position: Q3 2014 in Review

Austin W. Marxe & David M. Greenhouse held its Regulus Therapeutics (RGLS) position steady in Q3 2014 at 1,875 shares worth $1.54M. The position accounts for 0.21% of the portfolio, ranked #100.

Austin W. Marxe & David M. Greenhouse first reported a position in RGLS in Q2 2013 and has held it in 6 quarters since. The position peaked at $13.9M in Q2 2013. 49 funds tracked by Wall St. Rank hold RGLS as of Q3 2014.

Austin W. Marxe & David M. Greenhouse held 1,875 shares of Regulus Therapeutics worth $1.54M as of Q3 2014.
Austin W. Marxe & David M. Greenhouse left its Regulus Therapeutics share count unchanged in Q3 2014.
Regulus Therapeutics made up 0.21% of Austin W. Marxe & David M. Greenhouse's portfolio in Q3 2014, its #100 holding.
Austin W. Marxe & David M. Greenhouse first reported a position in Regulus Therapeutics in Q2 2013 and has held it in 6 quarters since.
Austin W. Marxe & David M. Greenhouse's Regulus Therapeutics position peaked at $13.9M in Q2 2013.
49 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q3 2014.

Based on Austin W. Marxe & David M. Greenhouse's 13F filing for Q3 2014, filed 14 Nov 2014.